Try our Advanced Search for more refined results

May 15, 2023

Securities and Exchange Commission v. Quanta, Inc. et al

Track this case

Case Number:

2:23-cv-03683

Court:

California Central

Nature of Suit:

Securities/Commodities

Judge:

Otis D. Wright, II

Government Agencies

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. May 15, 2023

    Scorpion Venom Drug Biz Hit With SEC Fraud Suit

    The U.S. Securities and Exchange Commission on Monday hit biopharmaceutical company Quanta and its CEO and executive vice president with a suit accusing the company of financial fraud over a 2021 press release the agency says misrepresented the U.S. Food and Drug Administration's response to a proposed clinical trial of the drug Escozine as a COVID-19 treatment.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login